

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.18934427 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.79631731 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.79631731 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.68538789 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.66011899 |
| 6 | positive regulation of interferon-alpha production (GO:0032727) | 5.15037936 |
| 7 | regulation of interferon-alpha production (GO:0032647) | 4.87787430 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.74665293 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.74665293 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.74665293 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.74665293 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.74665293 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.74665293 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.63946362 |
| 15 | response to type I interferon (GO:0034340) | 4.62424074 |
| 16 | type I interferon signaling pathway (GO:0060337) | 4.56154010 |
| 17 | cellular response to type I interferon (GO:0071357) | 4.56154010 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.15986141 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.11211569 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.10046145 |
| 21 | negative regulation of T cell mediated immunity (GO:0002710) | 4.07058951 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.04979606 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 4.02156696 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.96261899 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.96261899 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.92973095 |
| 27 | detection of molecule of bacterial origin (GO:0032490) | 3.88170657 |
| 28 | detection of other organism (GO:0098543) | 3.84280989 |
| 29 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.82863647 |
| 30 | positive regulation of interferon-beta production (GO:0032728) | 3.78987948 |
| 31 | T cell migration (GO:0072678) | 3.75560268 |
| 32 | B cell receptor signaling pathway (GO:0050853) | 3.75313458 |
| 33 | response to interferon-alpha (GO:0035455) | 3.73614476 |
| 34 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.73152014 |
| 35 | T-helper 1 type immune response (GO:0042088) | 3.73040909 |
| 36 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.71277561 |
| 37 | response to peptidoglycan (GO:0032494) | 3.69463882 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.65178979 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.65109838 |
| 40 | cellular response to interferon-beta (GO:0035458) | 3.58685733 |
| 41 | detection of bacterium (GO:0016045) | 3.53105090 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.52956039 |
| 43 | response to host immune response (GO:0052572) | 3.52956039 |
| 44 | detection of external biotic stimulus (GO:0098581) | 3.52046880 |
| 45 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.51333918 |
| 46 | microglial cell activation (GO:0001774) | 3.50657731 |
| 47 | regulation of B cell differentiation (GO:0045577) | 3.49496812 |
| 48 | positive thymic T cell selection (GO:0045059) | 3.48171766 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.44439422 |
| 50 | positive regulation of type 2 immune response (GO:0002830) | 3.42553794 |
| 51 | cellular response to exogenous dsRNA (GO:0071360) | 3.39157523 |
| 52 | positive regulation of B cell differentiation (GO:0045579) | 3.38548211 |
| 53 | respiratory burst (GO:0045730) | 3.35674231 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.34056340 |
| 55 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.32422124 |
| 56 | positive regulation of interleukin-17 production (GO:0032740) | 3.31777158 |
| 57 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.31259113 |
| 58 | positive regulation of defense response to virus by host (GO:0002230) | 3.30593808 |
| 59 | leukocyte aggregation (GO:0070486) | 3.30134236 |
| 60 | neutrophil activation (GO:0042119) | 3.29926363 |
| 61 | response to interferon-beta (GO:0035456) | 3.29360605 |
| 62 | necroptotic process (GO:0070266) | 3.28165418 |
| 63 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.26573888 |
| 64 | response to host (GO:0075136) | 3.26573888 |
| 65 | response to host defenses (GO:0052200) | 3.26573888 |
| 66 | defense response to protozoan (GO:0042832) | 3.25524574 |
| 67 | cellular response to zinc ion (GO:0071294) | 3.24981849 |
| 68 | granulocyte activation (GO:0036230) | 3.24640944 |
| 69 | regulation of tolerance induction (GO:0002643) | 3.22624601 |
| 70 | negative regulation of viral genome replication (GO:0045071) | 3.19941946 |
| 71 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.19613395 |
| 72 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.19165666 |
| 73 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.17452402 |
| 74 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.17313899 |
| 75 | negative thymic T cell selection (GO:0045060) | 3.17174004 |
| 76 | regulation of regulatory T cell differentiation (GO:0045589) | 3.14449095 |
| 77 | lymphocyte chemotaxis (GO:0048247) | 3.13191405 |
| 78 | negative T cell selection (GO:0043383) | 3.12341184 |
| 79 | regulation of RIG-I signaling pathway (GO:0039535) | 3.10325383 |
| 80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09651709 |
| 81 | response to protozoan (GO:0001562) | 3.09189273 |
| 82 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.08511281 |
| 83 | regulation of viral genome replication (GO:0045069) | 3.05366941 |
| 84 | detection of biotic stimulus (GO:0009595) | 3.04802283 |
| 85 | cellular extravasation (GO:0045123) | 3.03736148 |
| 86 | cellular response to virus (GO:0098586) | 3.03124494 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 3.02557843 |
| 88 | natural killer cell activation involved in immune response (GO:0002323) | 3.02424695 |
| 89 | regulation of type 2 immune response (GO:0002828) | 3.01818811 |
| 90 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.99732290 |
| 91 | macrophage activation (GO:0042116) | 2.98496526 |
| 92 | B cell mediated immunity (GO:0019724) | 2.98367626 |
| 93 | programmed necrotic cell death (GO:0097300) | 2.98239588 |
| 94 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.98226955 |
| 95 | positive regulation of tolerance induction (GO:0002645) | 2.97681119 |
| 96 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.96415788 |
| 97 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.95429038 |
| 98 | leukocyte cell-cell adhesion (GO:0007159) | 2.94806536 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 2.94740993 |
| 100 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93799117 |
| 101 | germinal center formation (GO:0002467) | 2.92333381 |
| 102 | response to interferon-gamma (GO:0034341) | 2.92094198 |
| 103 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91749139 |
| 104 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.91124721 |
| 105 | interferon-gamma production (GO:0032609) | 2.90817885 |
| 106 | regulation of antigen processing and presentation (GO:0002577) | 2.90519863 |
| 107 | cellular response to interleukin-15 (GO:0071350) | 2.90265910 |
| 108 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.90124679 |
| 109 | regulation of interferon-beta production (GO:0032648) | 2.89217330 |
| 110 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.88896025 |
| 111 | I-kappaB phosphorylation (GO:0007252) | 2.88714958 |
| 112 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.87306748 |
| 113 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.86015252 |
| 114 | natural killer cell mediated immunity (GO:0002228) | 2.86015252 |
| 115 | response to interleukin-15 (GO:0070672) | 2.84975816 |
| 116 | cellular response to interferon-alpha (GO:0035457) | 2.81380378 |
| 117 | response to muramyl dipeptide (GO:0032495) | 2.80817809 |
| 118 | regulation of response to interferon-gamma (GO:0060330) | 2.80792421 |
| 119 | mature B cell differentiation (GO:0002335) | 2.80031760 |
| 120 | positive regulation of humoral immune response (GO:0002922) | 2.79396294 |
| 121 | myeloid dendritic cell activation (GO:0001773) | 2.78128473 |
| 122 | NIK/NF-kappaB signaling (GO:0038061) | 2.77490248 |
| 123 | cellular response to interferon-gamma (GO:0071346) | 2.76615129 |
| 124 | B cell proliferation (GO:0042100) | 2.76151580 |
| 125 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.72932038 |
| 126 | defense response to virus (GO:0051607) | 2.70166549 |
| 127 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.68690490 |
| 128 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.67568095 |
| 129 | myeloid dendritic cell differentiation (GO:0043011) | 2.65807618 |
| 130 | positive T cell selection (GO:0043368) | 2.65706013 |
| 131 | positive regulation of interleukin-12 production (GO:0032735) | 2.65399748 |
| 132 | T cell selection (GO:0045058) | 2.64610793 |
| 133 | thymic T cell selection (GO:0045061) | 2.63137409 |
| 134 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.62748908 |
| 135 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.62351286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.30255202 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.35431423 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.24654365 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.69661235 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.59144945 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.03913053 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.63218941 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.61458243 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.37871674 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.37256130 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.14890825 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.07580260 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.90033465 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.74551130 |
| 15 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.61728078 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.50920110 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.45247836 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.43848782 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42290094 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.36965067 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.33580099 |
| 22 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.32963828 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29345750 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.15756311 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.10858341 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09314449 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.02970863 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02339763 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90252577 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.86570559 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78685402 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76572676 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73889961 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73613834 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72854784 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.70468615 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67549306 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.65481883 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62540366 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60005581 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58770379 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.57988558 |
| 43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41809309 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41393274 |
| 45 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39233927 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39102294 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38464435 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38166729 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37271829 |
| 50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34546468 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33525655 |
| 52 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27948459 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23921431 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.19707076 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19284411 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15174824 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11546855 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11149973 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10964354 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10005288 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08044769 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04309537 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03465910 |
| 64 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01816487 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01149230 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99794353 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99702484 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99469093 |
| 69 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98309612 |
| 70 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97792200 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97252530 |
| 72 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.96655712 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96187883 |
| 74 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95613950 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95243260 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95134210 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93395074 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93311936 |
| 79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93222390 |
| 80 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92741438 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91619519 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91479615 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90064792 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89810921 |
| 85 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89805919 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88539654 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86710163 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86442068 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86216293 |
| 90 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85106842 |
| 91 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84147287 |
| 92 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.83654072 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82666063 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81990247 |
| 95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80505493 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79059658 |
| 97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.79031215 |
| 98 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.77908781 |
| 99 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.77908781 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77070257 |
| 101 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76188395 |
| 102 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.75830865 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75806092 |
| 104 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.74254081 |
| 105 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.73816342 |
| 106 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.72984386 |
| 107 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.72476111 |
| 108 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.72458130 |
| 109 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72305594 |
| 110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72170520 |
| 111 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.70641782 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.67871109 |
| 113 | GATA3_26560356_Chip-Seq_TH1_Human | 0.62005900 |
| 114 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.61398992 |
| 115 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55610792 |
| 116 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.54548087 |
| 117 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.53403765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.44255473 |
| 2 | MP0009785_altered_susceptibility_to | 3.40373860 |
| 3 | MP0005387_immune_system_phenotype | 3.19950099 |
| 4 | MP0001790_abnormal_immune_system | 3.19950099 |
| 5 | MP0000685_abnormal_immune_system | 3.06626091 |
| 6 | MP0003436_decreased_susceptibility_to | 3.04984330 |
| 7 | MP0001800_abnormal_humoral_immune | 3.02867944 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.01991838 |
| 9 | MP0003724_increased_susceptibility_to | 2.96743689 |
| 10 | MP0005671_abnormal_response_to | 2.94477420 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.77858607 |
| 12 | MP0005025_abnormal_response_to | 2.73449601 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.66187536 |
| 14 | MP0002419_abnormal_innate_immunity | 2.64435146 |
| 15 | MP0002723_abnormal_immune_serum | 2.62390876 |
| 16 | MP0003303_peritoneal_inflammation | 2.61129216 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.44506466 |
| 18 | MP0001819_abnormal_immune_cell | 2.44271241 |
| 19 | MP0006082_CNS_inflammation | 2.43035764 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.21420850 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.18792318 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.04362951 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.02579602 |
| 24 | MP0004947_skin_inflammation | 2.02379371 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.01923629 |
| 26 | MP0002006_tumorigenesis | 1.99285503 |
| 27 | MP0002398_abnormal_bone_marrow | 1.98453547 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.96436675 |
| 29 | MP0000716_abnormal_immune_system | 1.92753121 |
| 30 | MP0002405_respiratory_system_inflammati | 1.88185735 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.87260907 |
| 32 | MP0001873_stomach_inflammation | 1.85496600 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.70709712 |
| 34 | MP0001853_heart_inflammation | 1.69647125 |
| 35 | MP0004510_myositis | 1.67381307 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.66490831 |
| 37 | MP0008260_abnormal_autophagy | 1.62444638 |
| 38 | MP0009764_decreased_sensitivity_to | 1.61464467 |
| 39 | MP0008469_abnormal_protein_level | 1.61162173 |
| 40 | MP0002429_abnormal_blood_cell | 1.58400806 |
| 41 | MP0002722_abnormal_immune_system | 1.55922076 |
| 42 | MP0005451_abnormal_body_composition | 1.55719395 |
| 43 | MP0009278_abnormal_bone_marrow | 1.53047256 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.47604338 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.45197203 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.44831852 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.39532706 |
| 48 | MP0003448_altered_tumor_morphology | 1.38627757 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.38458778 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.33790749 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.33790749 |
| 52 | MP0004883_abnormal_blood_vessel | 1.33680038 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.30495455 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.26472863 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.22330692 |
| 56 | MP0003690_abnormal_glial_cell | 1.22316848 |
| 57 | MP0005310_abnormal_salivary_gland | 1.21667510 |
| 58 | MP0000858_altered_metastatic_potential | 1.21518686 |
| 59 | MP0000343_altered_response_to | 1.20645738 |
| 60 | MP0003866_abnormal_defecation | 1.19867230 |
| 61 | MP0006054_spinal_hemorrhage | 1.13668223 |
| 62 | MP0002933_joint_inflammation | 1.13256610 |
| 63 | MP0001958_emphysema | 1.11193641 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.08164790 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.07151462 |
| 66 | MP0002136_abnormal_kidney_physiology | 1.05859259 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.00615510 |
| 68 | MP0005166_decreased_susceptibility_to | 0.99878966 |
| 69 | MP0002332_abnormal_exercise_endurance | 0.99564453 |
| 70 | MP0005174_abnormal_tail_pigmentation | 0.99519869 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 0.97675051 |
| 72 | MP0009763_increased_sensitivity_to | 0.93258070 |
| 73 | MP0003183_abnormal_peptide_metabolism | 0.92409200 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 0.92070424 |
| 75 | MP0003828_pulmonary_edema | 0.91796085 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 0.91474856 |
| 77 | MP0003091_abnormal_cell_migration | 0.89460278 |
| 78 | MP0003045_fibrosis | 0.88906834 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 0.87868632 |
| 80 | MP0003075_altered_response_to | 0.87427889 |
| 81 | MP0008004_abnormal_stomach_pH | 0.87100781 |
| 82 | MP0001851_eye_inflammation | 0.86040501 |
| 83 | MP0004381_abnormal_hair_follicle | 0.86014539 |
| 84 | MP0000490_abnormal_crypts_of | 0.85566780 |
| 85 | MP0004130_abnormal_muscle_cell | 0.85133712 |
| 86 | MP0005023_abnormal_wound_healing | 0.84295556 |
| 87 | MP0010307_abnormal_tumor_latency | 0.83166409 |
| 88 | MP0002132_abnormal_respiratory_system | 0.82184015 |
| 89 | MP0000371_diluted_coat_color | 0.80900562 |
| 90 | MP0009643_abnormal_urine_homeostasis | 0.80403223 |
| 91 | MP0000249_abnormal_blood_vessel | 0.80141424 |
| 92 | MP0005164_abnormal_response_to | 0.78848869 |
| 93 | MP0005360_urolithiasis | 0.78630339 |
| 94 | MP0010234_abnormal_vibrissa_follicle | 0.76888450 |
| 95 | MP0008874_decreased_physiological_sensi | 0.75581123 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.75050800 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.74208331 |
| 98 | MP0005390_skeleton_phenotype | 0.71307125 |
| 99 | MP0009840_abnormal_foam_cell | 0.71039205 |
| 100 | MP0001879_abnormal_lymphatic_vessel | 0.70987722 |
| 101 | MP0001663_abnormal_digestive_system | 0.67900665 |
| 102 | MP0003279_aneurysm | 0.67686695 |
| 103 | MP0003795_abnormal_bone_structure | 0.67651240 |
| 104 | MP0003186_abnormal_redox_activity | 0.65796880 |
| 105 | MP0000609_abnormal_liver_physiology | 0.65414085 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.64865564 |
| 107 | MP0002019_abnormal_tumor_incidence | 0.64574702 |
| 108 | MP0008438_abnormal_cutaneous_collagen | 0.64398223 |
| 109 | MP0005076_abnormal_cell_differentiation | 0.64102104 |
| 110 | MP0002928_abnormal_bile_duct | 0.62640414 |
| 111 | MP0002277_abnormal_respiratory_mucosa | 0.60243215 |
| 112 | MP0000604_amyloidosis | 0.58869305 |
| 113 | MP0002168_other_aberrant_phenotype | 0.58186687 |
| 114 | MP0001348_abnormal_lacrimal_gland | 0.56820710 |
| 115 | MP0003787_abnormal_imprinting | 0.54540703 |
| 116 | MP0000920_abnormal_myelination | 0.54499449 |
| 117 | MP0005381_digestive/alimentary_phenotyp | 0.54439417 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.52756870 |
| 119 | MP0009115_abnormal_fat_cell | 0.50912441 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.50451631 |
| 121 | MP0002877_abnormal_melanocyte_morpholog | 0.47262506 |
| 122 | MP0005075_abnormal_melanosome_morpholog | 0.45321836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.57198008 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.52146088 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.13534332 |
| 4 | Recurrent viral infections (HP:0004429) | 4.19502067 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.18776819 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.16782897 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.15106495 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.02690485 |
| 9 | Chronic otitis media (HP:0000389) | 3.94155795 |
| 10 | Recurrent bronchitis (HP:0002837) | 3.88304722 |
| 11 | Myositis (HP:0100614) | 3.85559359 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.83371904 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.77806639 |
| 14 | Recurrent skin infections (HP:0001581) | 3.70639932 |
| 15 | Vasculitis (HP:0002633) | 3.69643432 |
| 16 | Agammaglobulinemia (HP:0004432) | 3.54622391 |
| 17 | Granulocytopenia (HP:0001913) | 3.49224575 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.47450508 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.47450508 |
| 20 | Pustule (HP:0200039) | 3.46428038 |
| 21 | Cellulitis (HP:0100658) | 3.45676420 |
| 22 | Keratoconjunctivitis (HP:0001096) | 3.42594892 |
| 23 | Colitis (HP:0002583) | 3.39650063 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 3.27327860 |
| 25 | Abnormality of T cell number (HP:0011839) | 3.26876705 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.24260628 |
| 27 | Inflammation of the large intestine (HP:0002037) | 3.23648819 |
| 28 | Gastrointestinal stroma tumor (HP:0100723) | 3.23629674 |
| 29 | T lymphocytopenia (HP:0005403) | 3.22458839 |
| 30 | IgM deficiency (HP:0002850) | 3.18454063 |
| 31 | Hypochromic anemia (HP:0001931) | 3.18187694 |
| 32 | Orchitis (HP:0100796) | 3.16584952 |
| 33 | Meningitis (HP:0001287) | 3.10880312 |
| 34 | Nasal polyposis (HP:0100582) | 3.08527751 |
| 35 | Gastrointestinal inflammation (HP:0004386) | 3.08175092 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 3.04415055 |
| 37 | Optic neuritis (HP:0100653) | 3.04415055 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 3.03484225 |
| 39 | Abnormality of eosinophils (HP:0001879) | 3.02404339 |
| 40 | Abnormality of the nasal mucosa (HP:0000433) | 3.01244288 |
| 41 | Gingivitis (HP:0000230) | 3.00971998 |
| 42 | Periodontitis (HP:0000704) | 2.99420843 |
| 43 | Lymphopenia (HP:0001888) | 2.95770054 |
| 44 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.95587739 |
| 45 | Abnormality of T cells (HP:0002843) | 2.88333141 |
| 46 | Stomatitis (HP:0010280) | 2.86897206 |
| 47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.84784877 |
| 48 | Hematochezia (HP:0002573) | 2.79458140 |
| 49 | Obstructive lung disease (HP:0006536) | 2.78818885 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.78818885 |
| 51 | Osteomyelitis (HP:0002754) | 2.74066583 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.73456677 |
| 53 | Peritonitis (HP:0002586) | 2.72940459 |
| 54 | Chronic diarrhea (HP:0002028) | 2.69412208 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.66246214 |
| 56 | Emphysema (HP:0002097) | 2.65925136 |
| 57 | Panhypogammaglobulinemia (HP:0003139) | 2.62119987 |
| 58 | Gingival bleeding (HP:0000225) | 2.61015590 |
| 59 | Autoimmune hemolytic anemia (HP:0001890) | 2.58072780 |
| 60 | Arterial thrombosis (HP:0004420) | 2.57794967 |
| 61 | Abnormality of T cell physiology (HP:0011840) | 2.56666669 |
| 62 | Chronic sinusitis (HP:0011109) | 2.52258397 |
| 63 | Prostate neoplasm (HP:0100787) | 2.50374030 |
| 64 | Petechiae (HP:0000967) | 2.48353429 |
| 65 | Prolonged bleeding time (HP:0003010) | 2.48083563 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.47412543 |
| 67 | Myocardial infarction (HP:0001658) | 2.45573204 |
| 68 | Pulmonary embolism (HP:0002204) | 2.44959986 |
| 69 | Gangrene (HP:0100758) | 2.43928618 |
| 70 | Thrombocytosis (HP:0001894) | 2.43623722 |
| 71 | Neonatal hypoglycemia (HP:0001998) | 2.43442766 |
| 72 | IgA deficiency (HP:0002720) | 2.43327784 |
| 73 | Basal ganglia calcification (HP:0002135) | 2.42213993 |
| 74 | Hemoptysis (HP:0002105) | 2.40056357 |
| 75 | Anorexia (HP:0002039) | 2.39516393 |
| 76 | Recurrent sinusitis (HP:0011108) | 2.38599267 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 2.36500934 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36500934 |
| 79 | Abnormality of the fingertips (HP:0001211) | 2.34802559 |
| 80 | Thyroiditis (HP:0100646) | 2.32392378 |
| 81 | Leukocytosis (HP:0001974) | 2.30934907 |
| 82 | Recurrent pneumonia (HP:0006532) | 2.29721849 |
| 83 | Increased IgE level (HP:0003212) | 2.27805614 |
| 84 | Epistaxis (HP:0000421) | 2.26585063 |
| 85 | Recurrent lower respiratory tract infections (HP:0002783) | 2.26525656 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 2.26094109 |
| 87 | Abnormality of the pleura (HP:0002103) | 2.25463153 |
| 88 | Increased cerebral lipofuscin (HP:0011813) | 2.24356902 |
| 89 | Encephalitis (HP:0002383) | 2.22808704 |
| 90 | Skin ulcer (HP:0200042) | 2.18883920 |
| 91 | Abnormality of the prostate (HP:0008775) | 2.18116761 |
| 92 | Bronchitis (HP:0012387) | 2.18048320 |
| 93 | Abnormal platelet volume (HP:0011876) | 2.16443893 |
| 94 | Abnormality of the endocardium (HP:0004306) | 2.15849328 |
| 95 | Papilloma (HP:0012740) | 2.15476683 |
| 96 | Verrucae (HP:0200043) | 2.15476683 |
| 97 | Increased IgM level (HP:0003496) | 2.12521747 |
| 98 | IgG deficiency (HP:0004315) | 2.12395208 |
| 99 | Abnormality of the peritoneum (HP:0002585) | 2.11056989 |
| 100 | Restrictive lung disease (HP:0002091) | 2.11052431 |
| 101 | Eosinophilia (HP:0001880) | 2.09442357 |
| 102 | Joint swelling (HP:0001386) | 2.08611282 |
| 103 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07315600 |
| 104 | Glomerulopathy (HP:0100820) | 2.06042703 |
| 105 | Cheilitis (HP:0100825) | 2.04152410 |
| 106 | Urticaria (HP:0001025) | 2.03064712 |
| 107 | Keratoconjunctivitis sicca (HP:0001097) | 2.02744375 |
| 108 | Dysostosis multiplex (HP:0000943) | 2.02667496 |
| 109 | Glucose intolerance (HP:0000833) | 2.02127868 |
| 110 | Gastrointestinal infarctions (HP:0005244) | 2.01169155 |
| 111 | Sepsis (HP:0100806) | 1.99716374 |
| 112 | Skin rash (HP:0000988) | 1.99457920 |
| 113 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.96464627 |
| 114 | Enlarged epiphyses (HP:0010580) | 1.95466585 |
| 115 | Mitral stenosis (HP:0001718) | 1.94024620 |
| 116 | Keratitis (HP:0000491) | 1.94009344 |
| 117 | Alveolar cell carcinoma (HP:0006519) | 1.93429284 |
| 118 | Episodic fever (HP:0001954) | 1.92992865 |
| 119 | Purpura (HP:0000979) | 1.91388121 |
| 120 | Chest pain (HP:0100749) | 1.91216805 |
| 121 | Arthralgia (HP:0002829) | 1.91084162 |
| 122 | Polyneuropathy (HP:0001271) | 1.88477452 |
| 123 | Slow saccadic eye movements (HP:0000514) | 1.87964277 |
| 124 | Abnormality of the pericardium (HP:0001697) | 1.87308241 |
| 125 | Vertigo (HP:0002321) | 1.87287567 |
| 126 | Abnormality of B cell number (HP:0010975) | 1.85338971 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.85199148 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.85199148 |
| 129 | Abnormality of glycolipid metabolism (HP:0010969) | 1.85199148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.31517352 |
| 2 | TYK2 | 3.52649491 |
| 3 | MAP3K14 | 3.41209884 |
| 4 | JAK3 | 2.89932710 |
| 5 | IKBKE | 2.88493398 |
| 6 | TBK1 | 2.84572097 |
| 7 | JAK1 | 2.69661103 |
| 8 | TLK1 | 2.62267546 |
| 9 | TXK | 2.57712250 |
| 10 | BLK | 2.56618410 |
| 11 | KIT | 2.53919824 |
| 12 | IRAK4 | 2.44377730 |
| 13 | FGFR4 | 2.26180844 |
| 14 | RIPK4 | 2.25439918 |
| 15 | MAP3K13 | 2.01178577 |
| 16 | GRK7 | 1.98212663 |
| 17 | BMPR2 | 1.94923062 |
| 18 | ERN1 | 1.90230567 |
| 19 | CSK | 1.88787218 |
| 20 | PRPF4B | 1.86404478 |
| 21 | FGFR3 | 1.86298818 |
| 22 | ZAP70 | 1.85335783 |
| 23 | STK10 | 1.82957723 |
| 24 | BTK | 1.81004892 |
| 25 | IRAK3 | 1.76988075 |
| 26 | IKBKB | 1.74698065 |
| 27 | GRK6 | 1.74356820 |
| 28 | TGFBR2 | 1.67213301 |
| 29 | SYK | 1.64084898 |
| 30 | TEC | 1.62194225 |
| 31 | ITK | 1.58795928 |
| 32 | LRRK2 | 1.52088923 |
| 33 | CSF1R | 1.49346960 |
| 34 | MAP3K6 | 1.47853738 |
| 35 | MST4 | 1.45486861 |
| 36 | HCK | 1.45010229 |
| 37 | MAP3K10 | 1.42780388 |
| 38 | LCK | 1.37845341 |
| 39 | CAMKK2 | 1.27430963 |
| 40 | MST1R | 1.20836313 |
| 41 | MAP2K3 | 1.18680919 |
| 42 | MARK3 | 1.16377060 |
| 43 | LYN | 1.14934386 |
| 44 | TTN | 1.14131012 |
| 45 | PIM1 | 1.13028878 |
| 46 | TAOK3 | 1.10375604 |
| 47 | EPHB1 | 1.10252791 |
| 48 | CHUK | 1.08878919 |
| 49 | JAK2 | 1.03653917 |
| 50 | TRPM7 | 0.98539501 |
| 51 | CDK19 | 0.98210015 |
| 52 | NEK9 | 0.96418073 |
| 53 | RPS6KA4 | 0.95127725 |
| 54 | RET | 0.94612013 |
| 55 | PIK3CG | 0.91988783 |
| 56 | RIPK1 | 0.90034379 |
| 57 | MOS | 0.87295809 |
| 58 | MAP3K11 | 0.80496052 |
| 59 | MATK | 0.80104336 |
| 60 | CDC42BPA | 0.78716526 |
| 61 | FES | 0.78625816 |
| 62 | KDR | 0.78553477 |
| 63 | MAPK12 | 0.75761460 |
| 64 | STK4 | 0.74653587 |
| 65 | NME2 | 0.74150237 |
| 66 | MAP2K6 | 0.74086878 |
| 67 | MAP3K1 | 0.73541022 |
| 68 | TGFBR1 | 0.72598804 |
| 69 | FLT3 | 0.71266094 |
| 70 | PRKCQ | 0.70939354 |
| 71 | PKN2 | 0.69664674 |
| 72 | FRK | 0.69218122 |
| 73 | NLK | 0.68535003 |
| 74 | MAP3K3 | 0.67999796 |
| 75 | PTK6 | 0.67549665 |
| 76 | SIK2 | 0.66927053 |
| 77 | EPHA3 | 0.66671480 |
| 78 | PBK | 0.62756476 |
| 79 | PRKCH | 0.61790618 |
| 80 | PIM2 | 0.59459782 |
| 81 | TRIB3 | 0.58006143 |
| 82 | TAOK1 | 0.56990719 |
| 83 | ABL1 | 0.56856895 |
| 84 | IRAK2 | 0.56206563 |
| 85 | TAOK2 | 0.55391648 |
| 86 | NUAK1 | 0.55333576 |
| 87 | TIE1 | 0.55075782 |
| 88 | CAMK1D | 0.54822773 |
| 89 | EGFR | 0.51721418 |
| 90 | FGR | 0.50058919 |
| 91 | EEF2K | 0.49908146 |
| 92 | MAPK7 | 0.48995106 |
| 93 | CDK12 | 0.48407699 |
| 94 | CLK1 | 0.46831174 |
| 95 | GRK5 | 0.46733307 |
| 96 | ADRBK2 | 0.44930526 |
| 97 | MARK2 | 0.44685513 |
| 98 | CDK6 | 0.44682602 |
| 99 | PDK1 | 0.44421408 |
| 100 | PRKG2 | 0.44308885 |
| 101 | CDK9 | 0.44037153 |
| 102 | IRAK1 | 0.43656121 |
| 103 | PDGFRB | 0.42805216 |
| 104 | CAMKK1 | 0.42338441 |
| 105 | SGK3 | 0.42092568 |
| 106 | KSR2 | 0.41547648 |
| 107 | PRKCD | 0.40906689 |
| 108 | MAPK11 | 0.40720319 |
| 109 | MAP3K2 | 0.40599400 |
| 110 | SIK1 | 0.40182434 |
| 111 | PDPK1 | 0.37620328 |
| 112 | SIK3 | 0.36486738 |
| 113 | BMX | 0.35694766 |
| 114 | IGF1R | 0.35665475 |
| 115 | PTK2B | 0.34449089 |
| 116 | FYN | 0.33858551 |
| 117 | TNK2 | 0.33714614 |
| 118 | STK11 | 0.33683081 |
| 119 | HIPK2 | 0.33535214 |
| 120 | INSR | 0.33179732 |
| 121 | GRK1 | 0.32627019 |
| 122 | DYRK1B | 0.32507798 |
| 123 | STK3 | 0.31899213 |
| 124 | OXSR1 | 0.30060122 |
| 125 | PIK3CA | 0.29855880 |
| 126 | DDR2 | 0.27869482 |
| 127 | YES1 | 0.27714724 |
| 128 | EIF2AK2 | 0.26936978 |
| 129 | MAPKAPK2 | 0.25808036 |
| 130 | PRKD1 | 0.24034585 |
| 131 | MAP3K5 | 0.23006699 |
| 132 | CDK4 | 0.22565284 |
| 133 | MAP2K4 | 0.21726353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.09560328 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.04155207 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.83865735 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.56837442 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.56006064 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.55188547 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.52098375 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37144615 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.35366384 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.30391819 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.28155744 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24332271 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23524917 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.18508903 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.04342476 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.02669954 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 1.99461242 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.96716600 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.95513574 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.83990341 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.82894761 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.82133812 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.80056053 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.75151933 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.72099222 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.67537639 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63518721 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.58091526 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.56291301 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.43463238 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42499486 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41371214 |
| 33 | Hepatitis C_Homo sapiens_hsa05160 | 1.41310824 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36568946 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.35273489 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32883349 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.32846659 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.31435835 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24662266 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.24408543 |
| 41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.22767275 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.18816962 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14497391 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13501911 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.11481226 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10483375 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.06332512 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04094569 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95979677 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92812318 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89815790 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 0.86215708 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82107511 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80232258 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80119058 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77093555 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76594333 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71987070 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69818963 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67850601 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67776966 |
| 62 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65336193 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65319635 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.64621074 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63481010 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61066440 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58566305 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58060040 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57391421 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56593468 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.53646634 |
| 72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52772253 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51126723 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.48296678 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46929549 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45237574 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44550835 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44535621 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43823564 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42411202 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42222135 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41412564 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40602805 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40387063 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39670640 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39384039 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37845499 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37375616 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.37019766 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.36829258 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36185637 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35811680 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35550549 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34728529 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34073061 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32650498 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31684557 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30778501 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29037843 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.28014542 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27756267 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27475886 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25876833 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.25280833 |
| 105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.24902279 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.23813585 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.23180816 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22857244 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.22853563 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.21695723 |
| 111 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.21060676 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.20138768 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20086286 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.19606492 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.16988693 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.16620384 |

